FDA working to address injectable iron dextran shortage
Washington -- The U.S. Food and Drug Administration's Center for Veterinary Medicine is working with an injectable iron dextran supplier to try and relieve a shortage of the drug.
Washington
-- The U.S. Food and Drug Administration's Center for Veterinary Medicine is working with an injectable iron dextran supplier to try and relieve a shortage of the drug.
The drug, which is used for the prevention and treatment of iron deficiency in baby pigs, is considered medically necessary by FDA. FDA says a shortage of the drug could "result in indue suffering and disruption in the swine industry."
To help the supplier, Bimedia Inc., address the shortage, FDA says the company may temporarily import and distribute injectable 200 mg/ml iron dextran product into the United States from its Canadian branch in Ontario through February 2011, or until an adequate U.S. supply is available.
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More
